Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46
datasets available to search
ShareScore release 0.9.0
Dataset results
46 results for “Salivary gland cancer”
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
<p>This is a de-identified dataset accompanying the <em>Nature Medicine</em> publication titled "<strong>Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial</strong>", by Vos <em>et al. </em>(DOI: https://doi.org/10.1038/s41591-023-02518-x). It contains the clinical features and processed data of 64 patients with salivary gland cancer, treated with nivolumab and ipilimumab immunotherapy. These data underlie results reported in the article. Raw whole-exome and RNA sequencing data generated in this study have been made publicly available at SRA under BioProject number PRJNA940989.</p>
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02538510. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
ClinicalTrials.gov study NCT03146650. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
ClinicalTrials.gov study NCT03172624. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT00068237. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Iressa Study in Patients With Salivary Gland Cancer
ClinicalTrials.gov study NCT00509002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
ClinicalTrials.gov study NCT04209660. IPD Sharing: YES. Countries: 1. Publications: 1.
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
ClinicalTrials.gov study NCT00045669. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
ClinicalTrials.gov study NCT02867852. IPD Sharing: YES. Countries: 1. Publications: 1.
Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
ClinicalTrials.gov study NCT06923826. IPD Sharing: NO. Countries: 1. Publications: 8.
Cabozantinib in Advanced Salivary Gland Cancer Patients
ClinicalTrials.gov study NCT03729297. IPD Sharing: NO. Countries: 1. Publications: 2.
Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
ClinicalTrials.gov study NCT00002632. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer
ClinicalTrials.gov study NCT02048254. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers
ClinicalTrials.gov study NCT03749460. IPD Sharing: NO. Countries: 1. Publications: 0.
MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
ClinicalTrials.gov study NCT04895735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
ClinicalTrials.gov study NCT06805617. IPD Sharing: YES. Countries: 1. Publications: 0.
Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers
ClinicalTrials.gov study NCT00095563. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
ClinicalTrials.gov study NCT01613768. IPD Sharing: NO. Countries: 1. Publications: 0.
A macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer [Single nuclei RNAseq]
GEO Series GSE294017. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Gene expression profiling of mouse salivary gland cancer stem cells treated with Wnt inhibitors
GEO Series GSE73732. Mus musculus. 9 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.